The Anti-Infective Vaccine Market size continues to expand due to escalating demand for preventive healthcare and international funding initiatives. Market Size and Valuation Valued at several billion dollars, the market is projected to grow at a double-digit CAGR over the next decade. Rising infection rates, travel globalization, and aging populations are fueling demand for new and booster vaccines. Investment and Industrial Growth Major pharma companies like Pfizer, GSK, and Sanofi are expanding their vaccine portfolios. Emerging manufacturers in India, South Korea, and Brazil are contributing to global output. Infrastructure Expansion The creation of regional vaccine manufacturing clusters is reducing dependency on imports while improving supply chain resilience. Get detailed metrics from the Anti-Infective Vaccine Market size study. FAQs Q1: How large is the global market? A: It’s a multi-billion-dollar industry with strong annual growth. Q2: What’s driving the increase in size? A: R&D investments, global immunization campaigns, and population growth.